Home
>
National Drug Code (NDC)
>
Azulfidine
Azulfidine - 0013-0102-01 - (SULFASALAZINE)
Drug Information of Azulfidine
| Product NDC: | 0013-0102 |
| Proprietary Name: | Azulfidine |
| Non Proprietary Name: | SULFASALAZINE |
| Active Ingredient(s): | 500 mg/1 & nbsp; SULFASALAZINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Azulfidine
| Product NDC: | 0013-0102 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA007073 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19500620 |
Package Information of Azulfidine
| Package NDC: | 0013-0102-01 |
| Package Description: | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0013-0102-01) |
NDC Information of Azulfidine
| NDC Code | 0013-0102-01 |
| Proprietary Name | Azulfidine |
| Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0013-0102-01) |
| Product NDC | 0013-0102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SULFASALAZINE |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19500620 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | SULFASALAZINE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |
